Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01794767Phase 4Suspended
Phase 4, randomised trial of heparin in catheter obstruction and phlebitis (2 arms), sponsored by Università degli Studi di Firenze. Primary endpoint: Average length of stay on site of the catheter at 10 days. Started Jan 2013; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01794767.